ACON
HEALTHCAREAclarion Inc
Live · NASDAQ · May 9, Close
What's Moving ACON Today?
No stock-specific AI insight has been generated for ACON yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$3.28
Fundamentals
Trading
ACON News
20 articles- Natera (NTRA) Reports Q1 Loss, Tops Revenue EstimatesYahoo Finance·May 7, 2026
- Aclarion Announces Addition of First Private Practice Site in Los Angeles into CLARITY Trial to Further Accelerate EnrollmentYahoo Finance·May 7, 2026
- Aclarion Announces Inducement Grant to New Commercial Director, Western U.S.Yahoo Finance·May 6, 2026
- Aclarion Announces Second Commercial Agreement with Weill Cornell MedicineYahoo Finance·May 5, 2026
- Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical AdoptionYahoo Finance·Apr 30, 2026
- Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of NociscanGlobeNewswire Inc.·Apr 28, 2026
- Aclarion Announces $2.5 Million Stock Repurchase PlanYahoo Finance·Apr 22, 2026
- Aclarion Secures U.S. Patent Advancing Scalable, AI-Driven Assessment of Chronic Low Back PainYahoo Finance·Apr 16, 2026
- Aclarion Receives Pinnacle Award for AI InnovationYahoo Finance·Apr 14, 2026
- Aclarion Announces Agreement with Weill Cornell MedicineYahoo Finance·Apr 8, 2026
- Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician VideoYahoo Finance·Apr 7, 2026
- Echo Lake Capital Calls for the Resignation of David Neal From the Board of Directors of Aclarion Inc.Yahoo Finance·Mar 24, 2026
- Aclarion, Inc. Adopts Limited Duration Stockholder Rights PlanYahoo Finance·Mar 19, 2026
- Aclarion Publishes CEO Shareholder Letter Highlighting Strategic Progress and 2026 CatalystsYahoo Finance·Mar 19, 2026
- Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance SheetYahoo Finance·Mar 17, 2026
- Aclarion CEO Brent Ness to Attend LSI USA 2026Yahoo Finance·Mar 12, 2026
- Aclarion Publishes 2026 Shareholder Letter from the ChairmanYahoo Finance·Feb 5, 2026
- Aclarion Adds High-Volume Practice, Source Healthcare, to Support Nociscan Growth and Real-World Evidence GenerationYahoo Finance·Feb 3, 2026
- Aclarion Strengthens Balance Sheet and Extends Cash Runway Into 2028Yahoo Finance·Jan 13, 2026
- Aclarion Provides 2025 Update and 2026 Corporate OutlookYahoo Finance·Jan 8, 2026
All 20 articles loaded
Price Data
52-Week Range
$3.28
Fundamentals
Trading
About Aclarion Inc
Aclarion Inc (ACON) is a leading healthcare technology company dedicated to enhancing patient care through non-invasive diagnostic solutions leveraging advanced data analytics and machine learning. The firm specializes in innovative imaging techniques that streamline treatment pathways for musculoskeletal conditions, equipping healthcare professionals with actionable insights to improve clinical outcomes while reducing costs. Positioned at the forefront of the digital health revolution, Aclarion is well-equipped to address the rising demand for effective diagnostic tools, significantly contributing to the evolution of healthcare delivery in a dynamic environment. With a strong focus on advancing patient management, Aclarion is set to redefine standards in the healthcare sector.